A major clinical trial reveals that beta-blocker therapy after a heart attack may be harmful to women with preserved heart function, challenging standard treatment guidelines.
Most Recent Articles
AI-Enabled Stethoscope Increases Cardiac Diagnoses in Primary Care: Findings from the TRICORDER Trial
A landmark UK trial demonstrates that an AI-enabled stethoscope can more than double the detection rate of heart failure in primary care, enabling earlier diagnosis and treatment for patients.
REBOOT Trial: Beta-Blockers Show No Benefit Post-MI in Patients with Preserved Ejection Fraction
The REBOOT trial finds beta-blockers offer no benefit after uncomplicated heart attacks with preserved cardiac function, challenging a decades-old treatment paradigm and suggesting a need to update clinical guidelines.
Development and Psychometric Validation of the PLATO-11 for Clinical Monitoring of OSA
Discover PLATO-11, a new, validated 11-item questionnaire for efficiently tracking patient-reported symptoms and treatment response in adults with obstructive sleep apnea.
Intensive Lifestyle Intervention with a Calorie-Reduced Mediterranean Diet Lowers Type 2 Diabetes Incidence by 31%
An analysis of the PREDIMED-Plus trial reveals that a Mediterranean diet supplemented with caloric reduction and physical activity significantly reduces the incidence of type 2 diabetes in adults at risk.